The hype at the ObesityWeek conference in San Antonio, Texas, may be focused on phase 1 data for Viking Therapeutics' oral GLP-1/GIP dual agonist ...
News
- AstraZeneca still 'playing to win' in obesity, say execs - Fierce Biotech
- Meet the conservative women who are keeping their votes for Kamala Harris a secret | TPR
Thousands of people walk in a march in support of abortion rights near downtown San Antonio · Bioscience-Medicine · Texas OB-GYNs urge lawmakers to ...
- AstraZeneca Says Obesity Pill Well-Tolerated, Highly Competitive - Bloomberg News
... San Antonio, Texas. There was a “dose dependent increase in nausea and vomiting,” as can be expected with this molecule, Sharon Barr, executive ...
- bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) (“bioAffinity” or the “Company”), a biotechnology company ...
- BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast ...
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13 · In This Article:.